Raloxifene and estrogen effects on quality of life in healthy postmenopausal women: A placebo-controlled randomized trial

Ronald Strickler, Dale W. Stovall, Diane Merritt, Wei Shen, Mayme Wong, Sheryl L. Silfen

Research output: Contribution to journalArticlepeer-review

74 Scopus citations

Abstract

Objective: To assess the effects of raloxifene, estrogen, and placebo on quality of life in healthy, asymptomatic, postmenopausal women. Methods: In a multicenter, double-blind, 12-month study, 398 women were assigned randomly to one of four groups: raloxifene HC1, 60 (n = 97) or 150 mg/day (n = 100); conjugated equine estrogens, 0.625 mg/day (u = 96); or placebo (n = 105). The Women's Health Questionnaire, a validated quality-of-life instrument for perimenopausal and postmenopausal women, was administered at baseline and 3-month intervals. Results: Overall, quality of life from baseline to end point was preserved equally in all treatment groups. Six domains (depressed mood, somatic symptoms, memory/ concentration, sexual behavior, sleep problems, and perceived attractiveness) were unchanged in all groups. Three domains (menstrual symptoms, vasomotor symptoms, and anxiety/fears) were statistically significantly different among groups. Mean scores for menstrual symptoms significantly worsened and vasomotor symptoms significantly improved from baseline to end point in the estrogen group. Mean scores for vasomotor symptoms did not worsen at any point in the raloxifene 60 mg/day group. Mean anxiety/fears scores improved significantly during raloxifene 60 mg/day administration throughout treatment (P < .05), irrespective of previous hormone replacement therapy, baseline estradiol (E2) levels, or years postmenopause. Conclusion: Most quality-of-life domains were not affected by treatment with estrogen or raloxifene. Estrogen provided relief from vasomotor symptoms but caused menstrual symptoms. Raloxifene 60 mg/day improved anxiety levels in postmenopausal women.

Original languageEnglish
Pages (from-to)359-365
Number of pages7
JournalObstetrics and gynecology
Volume96
Issue number3
DOIs
StatePublished - Aug 23 2000
Externally publishedYes

Fingerprint

Dive into the research topics of 'Raloxifene and estrogen effects on quality of life in healthy postmenopausal women: A placebo-controlled randomized trial'. Together they form a unique fingerprint.

Cite this